These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy? De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639 [TBL] [Abstract][Full Text] [Related]
9. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424 [TBL] [Abstract][Full Text] [Related]
10. Neuropathology and molecular diagnosis of Synucleinopathies. Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583 [TBL] [Abstract][Full Text] [Related]
11. Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies. Moore K; Sengupta U; Puangmalai N; Bhatt N; Kayed R Mol Neurobiol; 2023 May; 60(5):2691-2705. PubMed ID: 36707462 [TBL] [Abstract][Full Text] [Related]
12. FKBP12-immunopositive inclusions in patients with α-synucleinopathies. Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765 [TBL] [Abstract][Full Text] [Related]
13. Differential Membrane Binding and Seeding of Distinct α-Synuclein Fibrillar Polymorphs. Shrivastava AN; Bousset L; Renner M; Redeker V; Savistchenko J; Triller A; Melki R Biophys J; 2020 Mar; 118(6):1301-1320. PubMed ID: 32059758 [TBL] [Abstract][Full Text] [Related]
14. Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity. Wojewska MJ; Otero-Jimenez M; Guijarro-Nuez J; Alegre-Abarrategui J Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686005 [TBL] [Abstract][Full Text] [Related]
15. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies. Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659 [TBL] [Abstract][Full Text] [Related]
16. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward. Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941 [TBL] [Abstract][Full Text] [Related]
17. Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Sevenich M; Honold D; Willuweit A; Kutzsche J; Mohrlüder J; Willbold D Neurochem Int; 2022 Dec; 161():105422. PubMed ID: 36252819 [TBL] [Abstract][Full Text] [Related]
18. Dutta AK; Armstrong C; Luo D; Das B; Spencer B; Rissman RA ACS Chem Neurosci; 2023 Mar; 14(5):885-896. PubMed ID: 36749600 [TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain. Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772 [TBL] [Abstract][Full Text] [Related]